|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 155.6 SEK | +4.57% |
|
+2.91% | -14.74% |
| Apr. 15 | Gisli Hennermark to Leave His Position as CEO of Surgical Science Sweden AB | CI |
| Mar. 12 | Surgical Science Sweden to Step Down; Search for Successor Starts | MT |
Surgical Science Sweden AB (publ) reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was SEK 802.54 million compared to SEK 366.78 million a year ago. Net income was SEK 187.97 million compared to SEK 86.25 million a year ago.
Basic earnings per share from continuing operations was SEK 3.7 compared to SEK 2.03 a year ago. Diluted earnings per share from continuing operations was SEK 3.69 compared to SEK 2.02 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.74% | 693M | |
| +4.71% | 32.47B | |
| +16.51% | 7.45B | |
| +23.49% | 3.89B | |
| -15.80% | 3.17B | |
| -27.19% | 1.28B | |
| -33.58% | 1.09B | |
| -33.74% | 902M | |
| +1.56% | 893M | |
| -23.93% | 857M |
SURGICAL SCIENCE SWEDEN AB 
